Hybridan Small Cap Feast: 22/04/2024
* A corporate client of Hybridan LLP
** Arranged by type of listing and date of announcement
*** Alphabetically arranged
**** Potential means Intention to Float (ITF) has been announced
Dish of the day
Admissions:
None
Delistings:
None
What’s baking in the oven? **
Potential**** Initial Public Offerings:
None
Reverse Takeovers:
16 April 2024: Concurrent with its Admission to trading on AIM, Electric Guitar is proposing to acquire the entire issued share capital of 3radical Limited for a consideration of approximately £1.3m, payable by the issue of new ordinary shares in Electric Guitar. The Acquisition constitutes a reverse takeover under the Listing Rules and therefore shareholder approval for the Acquisition is being sought at a general meeting of Electric Guitar to be convened for 1 May 2024.
17 April 2024: Hostmore plc announces that it has reached agreement on a non-binding basis for a proposed all-share acquisition of TGI Fridays, Inc. The Proposed Transaction would result in existing Hostmore shareholders holding 36% of the enlarged business upon completion (the Combined Group), with TGI Fridays shareholders holding a 64% shareholding. TGI Fridays is expected to be purchased for an enterprise value of £177m, or approximately 5.4x its FY23 underlying EBITDA. The Combined Group is expected to be renamed TGI Fridays plc, with its shares admitted to trading on the LSE’s Main Market. Completion of the Proposed Transaction expected to be by the end of Q3 2024.
Change of Market:
8 April 2024: a multi-channel value retailers of books, arts and crafts, stationery, toys and games, offering customers a differentiated proposition as a value alternative to full price specialist retailers. The Company is listed on the premium segment of the Main market of the London Stock Exchange. The Company has announced its intention to change to the AIM market on 3 May 2024. Currently the market capitalisation of TheWorks is £16m.
Banquet Buffet***
8.75p £9.7m (AFRN.L)
The B2B video streaming solutions Company announces that, following fourteen years of service, Donald McGarva will step down from his role as CEO and leave the Company in October 2024. The Board would like to take this opportunity to thank Donald for his contribution to the Company and wish him well for the future.
0.9p £15.7m (ARV.L)
The Company announces the appointment of Ms Elizabeth Henson as a Non-Executive Director of the Company with immediate effect. Ms Henson is an international lawyer with over 35 years of global experience in corporate governance, business and professional services. Ms Henson was a Senior Partner at PwC based in London between 2007 and 2019, and prior to that, she was a commercial partner in an accountancy firm focused on international business.
2.5p £32.2m (BBSN.L)
The digital advertising and technology services Company announces its audited results for the year ended 31 December 2023. Revenue increased 13% to £35.7m (2022: £31.7m), profit before tax decreased 24% to £1.1m (2022: £1.5m) due to the acquisition and restructuring of SocialChain in H1 FY23, and furthermore, the net cash balance increased 10% to £6.8m (2022: £6.2m). Trading in 2024 to date has been encouraging and is ahead of the prior year. The Board is confident in meeting full year market expectations.
15.5p £22.5m (CTL.L)
The exploration and development Company advancing lithium projects in Chile announces it has completed the planned acquisition of the 23 Laguna Verde licences previously subject to an option agreement resulting in the Company now having full ownership of the full 108 mining licences comprising. In the Directors' opinion, this enhances the potential future returns to shareholders, while reducing risk, given the asset's now relatively advanced stage. The Company has also been advised that taking full ownership of the Licenses clears the path for the planned dual-listing on the Australian Securities Exchange.
6.85p £26.5m (EAAS.L)
The net zero energy services provider announces it has signed an estimated £5.2m contract with Spire Healthcare Group to provide a PV system across 38 sites. Revenues under the contract are expected to be recognised in FY24, supporting the Group's existing forecasts for the period. The contract award follows the successful installation of a first solar trial site. Spire is a provider of private healthcare in the UK, operating a network of 39 hospitals and over 50 clinics, medical centres and consulting rooms across England, Wales and Scotland.
52.5p £67.2m (FEN.L)
The professional and financial services firm operating in the Personal Injury and Clinical Negligence space announces its final results for the 12 months ended 31 December 2023. Revenue increased 32% to £32.8m (2022: £24.8m), adjusted EBITDA increased 31% to £8.0m (2022: £6.1m) and cash generated from operating activities increased 357% to £3.2m (2022: £0.7m). Q1 has been a record in numbers terms for pipeline of opportunities across the Group.
162.5p £121.5m (HUW.L)
The investment vehicle which builds shareholder value participating across a spread of Lloyd's syndicates announces that Edward Fitzalan-Howard, the Duke of Norfolk, has tendered his resignation as Non-Executive Director of the Board with effect from 19 April 2024. The Board of Directors accepts and respects his decision and expresses gratitude for his contributions throughout his tenure with the Company.
38.5p £38.6m (MIND.L)
The global provider of human capital and business improvement solutions announces a trading update for its financial year ended 31 March 2024. Revenue for H2 FY24 increased 15% to £24m (H1 FY24: £21.4m), expected EBITDA will be £3.8m (H1 FY24: £4.1m loss) and as at 31 March 2024, the Group had sufficient liquidity with cash of £1.4m and access to a £2m undrawn loan facility. Following the improved H2 performance Mind Gym has entered the new financial in year in an enhanced financial and operating position.
65.75p £56.8m (TENG.L)
The global concierge platform driving customer loyalty for global financial institutions and other premium brands announces its unaudited interim results for the six months ended 29 February 2024. Net Revenue at £30.9m (H1 2023: £30.9m), profit before tax of £0.3m (H1 2023: £0.4m), and net cash was £1.9m (H1 2023: £0.5m ). Since the end of the first half of the financial year, Ten has launched new contracts, most notably with Emirates NBD Bank, and continues to convert its strong pipeline of new business.
3.45p £4.6m (VAL.L)
The life sciences Company focusing on early-stage cancer therapeutics and women's health announces that, further to the announcements of 29 February and 19 March 2024, the Company has appointed Martin Gouldstone and Adrian de Courcey as Non-executive Directors with immediate effect, following completion of standard regulatory due diligence. In addition, Ray Horn has been appointed as a Board observer.
Status of this Note and Disclaimer
This document has been issued to you by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific entity and is not a personal recommendation to anyone. Recipients should make their own investment decisions based upon their own financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
The information contained in this document is based on materials and sources that are believed to be reliable; however, they have not been independently verified and are not guaranteed as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information in this document nor should it be relied upon as such.
Any and all opinions expressed are current opinions as of the date appearing on this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.
This document is sent to you as market commentary only. As market commentary this document does not constitute any of (i) investment research and financial analysis or other forms of general recommendation relating to transactions in financial instruments for the purposes of the UK retained version of section B of annex I to Directive 2014/65/EU ("MIFID II Directive"); or (ii) investment research as defined in the UK retained version of article 36(1) of Commission Delegated Regulation 2017/565/EU made pursuant to the MIFID II Directive; or (iii) non-independent research (as such term is defined in the Financial Conduct Authority's Conduct of Business Sourcebook).
This document should not be relied upon as being an independent or impartial view of the subject matter. The individuals who prepared this document may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority's Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as "relevant persons"). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority's Conduct of Business Sourcebook.
Neither this document nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.
Disclaimer & Declaration of Interest
The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.